Peer-reviewedCC BY 4.0JAMA Network Open
Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence
- 1Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City
- 2Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa
Related
- Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia: a multicenter real-world evaluation using the international TriNetX database
- Cefazolin versus Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Chlorhexidine MIC distribution, efflux pump gene profiles, and genotypic characteristics among clinical methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates
- Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
- Routine Serial Follow-up Blood Cultures After a Negative Result Within 48 Hours of Methicillin-susceptible Staphylococcus aureus Bacteremia: Low Yield, High Cost
BibTeX
@article{goto2026cefazolin,
title = {{Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence}},
author = {Michihiko Goto},
journal = {JAMA Network Open},
year = {2026},
month = nov,
doi = {10.1001/jamanetworkopen.2026.43842},
url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856579},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence
AU - Michihiko Goto
PY - 2026
DA - 2026/11/12
JO - JAMA Network Open
DO - 10.1001/jamanetworkopen.2026.43842
UR - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856579
SN - 2574-3805
ER -